SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-23-045083
Filing Date
2023-08-29
Accepted
2023-08-29 16:31:13
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 july_2023_pipe_s-3.htm S-3 513657
2 EX-5.1 cmra-ex5_1.htm EX-5.1 38204
3 EX-23.1 cmra-ex23_1.htm EX-23.1 5676
4 EX-FILING FEES cmra-exfiling_fees.htm EX-FILING FEES 44074
5 GRAPHIC img139950163_0.jpg GRAPHIC 22298
6 GRAPHIC img184256161_0.jpg GRAPHIC 37030
  Complete submission text file 0000950170-23-045083.txt   684395
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 (617)871-2101
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 874706968 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274253 | Film No.: 231222336
SIC: 2834 Pharmaceutical Preparations